Stomach cancer Doctors Abroad — Page 2

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center in Israel. He was recognized by Forbes as one of the country's top physicians. Prof. Nachmany specializes in robotic surgery for the liver, pancreas, and bile ducts. He focuses on treating gastrointestinal neuroendocrine tumors using minimally invasive techniques.

• Board certified in General Surgery, HPB Surgery, and Abdominal Organ Transplantation.
• Completed surgical fellowships at the prestigious Thomas E. Starzl Transplantation Institute.
• Performs complex Whipple procedures and robotic low anterior resections.
• Author of numerous surgical oncology studies in journals like Cancer Research.

Prof. Sezer Sağlam specializes in gastrointestinal oncology with extensive experience at Istanbul University Oncology Institute.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Works at Gayrettepe Florence Nightingale Hospital

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.

• Contributor to the international expert panel on VHL management guidelines.
• Authored over 40 peer-reviewed papers in journals like JAMA and Gastroentrology.
• Maintains research affiliations with the NIH and the Weizmann Institute.
• Performs specialized NET treatments, including Lutetium-177 therapy and PRRT.

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Professor Doctor Sefik Igdem specializes in Radiation Oncology at Gayrettepe Florence Nightingale Hospital, focusing on advanced treatments like Truebeam Stx Technology.

• Expert in head and neck cancers
• Uses conformal treatments for precise radiation therapy
• Professor at T.R Demiroğlu Bilim University

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.

• Completed surgical oncology training at Memorial Sloan Kettering in New York.
• Uses NanoKnife and microwave liver ablation for targeted tumor treatment.
• Maintains ESSO certification for cytoreductive surgery and HIPEC.
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Serkan Keskin has performed over 1,100 procedures in medical oncology, specializing in chemotherapy and targeted therapy. He achieved first place on Turkey's Medical Oncology Proficiency Exam.

• 25 years of experience as a respected medical oncologist, focusing on challenging cancer types
• Best Poster Award at the 19th National Cancer Congress in 2011
• Member of the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO)
• Published 42 articles in international journals
• Trained in Medical Oncology Minor Speciality at Istanbul University Institute of Oncology

900+ oncology procedures performed – Dr. Solak specializes in stomach cancer at Hisar Hospital Intercontinental.

• 20 years of experience in oncology
• Trained at Hacettepe University and UT MD Anderson Cancer Center
• Fellowship in gastrointestinal cancers at Hacettepe University Cancer Institute
• Deals with complex cases of breast, lung, and head-neck cancers

Prof. Dr. Suleyman Alici is a highly experienced physician specializing in stomach cancer treatment at Hisar Hospital Intercontinental.

• Recognized by peers and patients for his expertise
• Holds the prestigious title of Professor
• Works at a leading international medical facility

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 international publications. She treats gastrointestinal cancers at Anadolu Medical Center.

• Member of European Society of Medical Oncology (ESMO)
• Expert in precision medicine for stomach cancer
• Professor at Haliç University in Istanbul
• Completed advanced training in immunotherapy at Mount Vernon Cancer Center

Prof. Kivanc Derya Peker has performed over 400 stomach cancer surgeries and trained at Mayo Clinic's Hepatopancreatobiliary Surgery Clinic.

• 22 years of experience in gastroenterology surgery
• Co-founded the HPB Surgery unit at Dr. Sadi Konuk Hospital
• Specializes in pancreatic, liver, and stomach cancer surgeries
• Holds accreditation from the Turkish HPB Association
• Performed over 900 procedures including kidney transplants